Amer Sports Q3 Beat and Raised Guidance Signal Continued Momentum, But Inventory and Comp Durability Remain Key Watchpoints
Read source articleWhat happened
Amer Sports reported better-than-expected Q3 FY26 results and raised its full-year guidance, extending the strong performance seen in Q1. The news follows a first quarter where revenue grew 32% YoY to $1.945B with adjusted EBITDA margin of 22.2%, but inventories rose 33% YoY and the auditor flagged an internal-control material weakness. The Q3 beat suggests demand remained robust through the summer and fall, potentially addressing concerns about inventory digestion and Technical Apparel comp durability. However, the Benzinga headline lacks specifics on segment-level performance, inventory levels, and gross margin, so it is unclear whether the company improved on its operational risk factors. In the context of a premium valuation (43.6x P/E and 18.8x EV/EBITDA at last check), the market will focus on whether growth is comp-driven or store-count-driven and whether inventory normalized versus sales.
Implication
The positive Q3 news reduces near-term downside risk, but the core uncertainties from the master report remain unresolved. Key metrics to watch in the upcoming earnings release are Technical Apparel omni-comp (must stay above 15%), inventory growth (should decelerate to below 15-20% YoY), and gross margin stability. If those metrics confirm improvement, the thesis would shift from WAIT to a potential BUY, especially if the stock approaches the attractive entry range. However, until the company demonstrates that growth is comp-driven rather than store-count-driven and that inventory is not building ahead of demand, the premium valuation leaves limited margin for error. Investors should maintain a patient stance and use any pullback toward the $30 level as a potential entry if Q3 details validate the thesis.
Thesis delta
The Q3 beat and raised guidance partially validate the demand strength thesis, reducing the probability of the bear scenario. However, the lack of detail on inventory and comp metrics means the core watchpoints remain unresolved. The thesis shifts from 'wait for Q2 evidence' to 'wait for confirmation that inventory normalized and comps held above 15% in Q3,' with a slight upward bias if those metrics improve.
Confidence
Medium